BioRestorative Therapies's total assets for Q3 2024 were $14.57M, a decrease of -9.59% from the previous quarter. BRTX total liabilities were $4.58M for the fiscal quarter, a -13.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.